BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Down 62.5% in August

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large drop in short interest in August. As of August 31st, there was short interest totaling 30,094 shares, a drop of 62.5% from the August 15th total of 80,226 shares. Based on an average trading volume of 170,903 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Institutional investors have recently bought and sold shares of the stock. SouthState Bank Corp bought a new position in BlackRock Health Sciences Term Trust during the 1st quarter valued at $29,000. PNC Financial Services Group Inc. purchased a new position in BlackRock Health Sciences Term Trust during the 1st quarter worth $35,000. Integrated Wealth Concepts LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 2nd quarter worth $46,000. Fifth Third Bancorp bought a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter worth $142,000. Finally, Prospera Financial Services Inc purchased a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at about $179,000.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ traded down $0.21 during midday trading on Tuesday, reaching $16.06. 228,025 shares of the company were exchanged, compared to its average volume of 209,826. The company’s fifty day moving average price is $16.08 and its 200 day moving average price is $15.01. BlackRock Health Sciences Term Trust has a one year low of $13.70 and a one year high of $17.25.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Friday, December 11th. This represents a c) annualized dividend and a dividend yield of 8.2%.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.